Pt(IV) anticancer prodrugs bearing an oxaliplatin scaffold: what do we know about their bioactivity?

Oxaliplatin( iv ) prodrugs, classified by the role of their axial ligands, are presented with a focus on their in vitro stability and activity in in vivo models, illustrating their potential to address current Pt-based chemotherapy's main limitations.